What Oral Alternatives Exist to Vaginal Estrogen for GSM?

If you are experiencing vaginal dryness and painful sex due to genitourinary syndrome of menopause (GSM, sometimes called vulvovaginal atrophy) but want to avoid messy creams, rings, or suppositories, there is an FDA-approved oral alternative. It is a daily prescription pill called ospemifene (brand name Osphena) ^[1]. Unlike traditional systemic hormone replacement therapy, ospemifene is not an actual estrogen ^[1][2]. Instead, it is a medication taken by mouth that treats moderate-to-severe pain with sex and vaginal dryness from the inside out ^[3][4].

However, because it is a pill that is absorbed into your entire bloodstream (systemic exposure), it carries different risks compared to low-dose vaginal estrogen, which stays mostly local to the vagina ^[5][6].

How Ospemifene Works (The “SERM” Mechanism)

Ospemifene belongs to a class of drugs known as Selective Estrogen Receptor Modulators (SERMs) ^[1]. To understand how a SERM works, imagine estrogen receptors in your body as locks, and estrogen as the key that turns them on. A SERM is a unique master key that can unlock the estrogen doors in some tissues while blocking or ignoring them in others ^[2].

When you take ospemifene, it acts like an estrogen in your vaginal tissue ^[2]. There, it can thicken the vaginal walls, lower the vaginal pH, and increase natural moisture, which helps relieve the pain of intercourse ^[3][7]. However, this medication is tissue-selective, meaning it does not act exactly like estrogen everywhere in the body ^[2].

Importantly, it is not neutral everywhere else. It has estrogen-agonist (stimulating) effects on the endometrium (the lining of the uterus) ^[6][8]. This systemic action is why ospemifene carries serious warnings and requires careful medical supervision ^[5][6].

Taking Ospemifene

The standard dosage for ospemifene is one 60 mg tablet taken by mouth once daily with food ^[3][9]. Because it is a systemic medication, it may interact with other drugs you are taking, so your prescriber and pharmacist must review your entire medication list. If your symptoms do not improve after several weeks, you should follow up with your doctor.

Serious Risks and Boxed Warnings

Because ospemifene has systemic estrogen-like effects in certain tissues, the FDA requires a “boxed warning” (the strictest warning for prescription drugs) on the medication to highlight severe risks:

• Endometrial Cancer: Because ospemifene stimulates the lining of the uterus, it can cause the lining to thicken (endometrial hyperplasia) and may increase the risk of endometrial cancer ^[6][8]. Any unexpected, abnormal, or postmenopausal vaginal bleeding while taking this medication must be evaluated by a doctor immediately ^[10]. Endometrial safety has not been studied in clinical trials beyond one year ^[6][10].
• Cardiovascular Disorders: There is a potential risk for venous thromboembolism (VTE), which means dangerous blood clots forming in the deep veins of the legs (deep vein thrombosis) or traveling to the lungs (pulmonary embolism) ^[5][6]. There is also a risk of stroke and heart attack ^[5][6].

Who Should Not Take Ospemifene?

Due to these risks, ospemifene should not be used (is contraindicated) in people who:

• Have active or a past history of blood clots (DVT or PE) ^[5].
• Have an active or past history of arterial thromboembolic disease, such as a stroke or heart attack ^[5].
• Have undiagnosed abnormal genital bleeding ^[10].
• Have known or suspected estrogen-dependent cancers ^[10].

If you are scheduled for a surgery that requires prolonged bed rest or immobilization, your doctor will likely instruct you to stop taking ospemifene several weeks beforehand to reduce the risk of blood clots ^[11].

Emergency Symptoms to Watch For

Seek emergency medical care immediately if you experience:

• Sudden shortness of breath or sudden chest pain
• Coughing up blood
• Swelling, warmth, or pain in just one leg
• Sudden weakness or numbness in the face, arm, or leg
• Sudden trouble speaking or sudden vision changes

Common Side Effects

While the severe risks are rare, some side effects are common:

• Hot Flashes: This is the most common side effect. Because of its selective estrogen-antagonist (blocking) effects in certain tissues, about 8.5% of women in clinical trials taking ospemifene experienced hot flashes, compared to about 3.2% taking a placebo ^[9][11]. These usually occurred most often during the first four weeks of treatment ^[9].
• Other Mild Effects: Some patients also report urinary tract infections, headaches, muscle spasms, and vaginal discharge ^[11][6].

Important Considerations

Breast Cancer Survivors

The safety of ospemifene for people with a history of breast cancer has not been established ^[10]. Current medical guidelines generally advise that there is insufficient data to confirm its safety for breast cancer survivors ^[10][12]. It should only be considered after a highly individualized risk discussion and with direct input from your oncology team ^[10].

Comparing Your Options

When deciding on a treatment for vaginal dryness and pain with sex, it is helpful to weigh ospemifene against other options:

• Non-hormonal moisturizers and lubricants: The safest first-line approach, carrying no systemic hormonal risks, but may not be enough for severe atrophy ^[13].
• Low-dose vaginal estrogen or vaginal prasterone (DHEA): These are applied directly to the vagina. While they can be “messier,” they have very low systemic absorption and lower whole-body risks compared to an oral pill ^[13][14].
• Systemic Menopausal Hormone Therapy (MHT): Traditional estrogen pills or patches. If you also suffer from severe hot flashes, your doctor might discuss systemic MHT, which treats both hot flashes and vaginal dryness ^[13][14]. However, systemic MHT carries its own risks, and if you still have a uterus, you must take a progestogen alongside the estrogen to protect your uterine lining ^[13]. Systemic MHT is not typically recommended if vaginal symptoms are your only concern ^[14][15].